CYP2C9 allelic variants: ethnic distribution and functional significance

This publication has 69 references indexed in Scilit:

• Pharmacogenetics of Warfarin Elimination and its Clinical Implications
  Clinical Pharmacokinetics, 2001
• Analyses of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases
  Carcinogenesis: Integrative Cancer Research, 1999
• Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
  The Lancet, 1999
• Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish Population
  Biochemical and Biophysical Research Communications, 1999
• Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California
  Pharmacogenetics, 1996
• Factors determining the maintenance dose of warfarin in Chinese patients
  QJM: An International Journal of Medicine, 1996
• P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature
  Pharmacogenetics, 1996
• A 2.4-Megabase Physical Map Spanning the CYP2C Gene Cluster on Chromosome 10q24
  Genomics, 1995
• Gene Structure and Upstream Regulatory Regions of Human CYP2C9 and CYP2C18
  Biochemical and Biophysical Research Communications, 1993
• Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase
  Biochemistry, 1988